Earlier in October, the U.S. Judicial Panel on Multidistrict Litigation (JPML) issued a consolidation order for Taxotere lawsuits filed in federal courts around the country.  The claims will now proceed in a multidistrict litigation (MDL) against defendant Sanofi-Aventis.  The ruling affects at least 33 cases that had been pending in 16 different U.S.... Read more »

A plaintiff claims that use of diabetes drug Invokana led to kidney failure.  The plaintiff only took the medication for two months before she began having life-threatening side effects that forced her to stop taking Invokana and seek medical treatment for her kidney problems.  Judith Buchanan filed her lawsuit on September 16 in... Read more »

A plaintiff who recently filed a talcum powder lawsuit against Johnson & Johnson involving their talc-based products has also laid grounds for the possibility of a class action to be formed.  The plaintiff in this case states that the hundreds and possibly thousands of women who have been diagnosed with ovarian cancer as... Read more »

A woman has filed a talcum powder lawsuit against Johnson & Johnson, alleging the pharmaceutical giant failed to warn women about the potential risks associated with using their products containing talc.  The plaintiff claims she used the products regularly for many years, leading to a diagnosis of ovarian cancer in... Read more »

Eight Androgel lawsuits have been selected out of around 5,500 cases currently pending to serve as bellwether trials in the coordinated litigation.  The bellwether trials are carefully selected to provide insight into how juries might respond to evidence and testimony in future trials.  These early trials also can serve as... Read more »

A woman that developed ketoacidosis after taking the diabetes drug Invokana has filed a lawsuit against the drug’s manufacturers.  Sheryl Desalis is claiming in her complaint that Janssen Pharmaceuticals, Johnson & Johnson and Mitsubishi Tanabe Pharma failed to provide proper warnings about the risks of diabetic ketoacidosis associated with their... Read more »

A teenager has been awarded $70 million by a jury in his Risperdal lawsuit – the largest jury award to date involving Risperdal litigation.  The plaintiff and his mother allege use of Risperdal for a number of years during childhood led to the growth of male breasts, a condition known... Read more »

A review of adverse event reporting to the FDA in 2015 conducted by the Institute for Safe Medication Practices (ISMP) has revealed that Xarelto (rivaroaban) and its side effects were connected to more cases of serious harm than any other drug included in the survey.  The next-generation anticoagulant drug came... Read more »

Chemotherapy-related hair loss is common, with about 65% of chemo patients losing their hair.  However, hair loss is a harrowing event; according to studies, nearly half of female chemo patients consider it to be the most traumatic part of chemo.  The profound impact of hair loss is known to strike... Read more »

Defendants Johnson & Johnson allegedly ignored the link between long-term talc powder use and ovarian cancer, claims a new joint lawsuit filed by 10 plaintiffs.  The plaintiffs include six families of women who lost their lives to ovarian cancer that was allegedly caused by the long-term use of talc for... Read more »

Sign Up for Lawsuit Updates

Email

This field is required. 

About Drug Reporter

DrugReporter.com provides up to date information on lawsuits involving dangerous drugs that affect consumers throughout the country.  This website is sponsored by Eisbrouch Marsh, LLC, a national law firm with principal offices located at 50 Main Street Hackensack, NJ 07601.  The information found here is not legal advice.  Visitors should retain legal counsel before making legal decisions.  If you believe certain facts contained herein are in error, please contact the webmaster. 

This website contains attorney advertising. The material posted here is not intended to create nor does it constitute, a lawyer-client relationship.  Visitors to the site should not act upon information here without first seeking professional counsel.  Prior results do not guarantee a similar outcome in future cases.